Osivax Alternatives & Competitors

12 companies similar to Osivax — Pioneering A New Class of Universal Vaccines

Mucosis

Pioneering needle-free mucosal vaccines for natural and robust immunity.

Venture round $15.60M

Biotechnology Health Care

Novavax

Powering innovation. Protecting health.

970 Post-IPO Equity $2.71B

Gaithersburg, United Stat...

Biotechnology Health Care +1

VBI Vaccines Inc.

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

57 Post-IPO Equity $186.24M

Cambridge, United States

Biotechnology Health Care

Providence Therapeutics

Where Hope and Science Intersect

56 $5.60M

Calgary, Canada

Biotechnology Health Care +1

Track all Osivax competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

iTeos Therapeutics

Cancer Immunotherapies by Design

186 Post-IPO Equity $362.74M

Cambridge, United States

Biotechnology Health Care

FLUGEN, INC.

Transforming vaccine efficacy in respiratory disease.

6 Grant $71.35M

Biotechnology Health Care +1

IO Biotech

Break Boundaries. Ignite Change.

91 Post-IPO Equity $198.00M

Denmark

Biotechnology Health Care +1

AdaptVac

AdaptVac aims to accelerate the development of safe and efficacious therapeutic and prophy...

10 Grant $800.00K

Horsholm, Denmark

Biotechnology Health Care +1

Affinivax Inc.

23 Grant $377.49M

Cambridge, United States

Biotechnology Health Care +1

ImmunoGenesis, Inc.

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mech...

14 Venture round $28.00M

Houston, United States

Biotechnology Health Care +2

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

Curevo Vaccine

A clinical-stage biotech company developing amezosvatein, a vaccine for shingles and chick...

44 Acquired $196.00M

Bothell, United States

Biopharma Biotechnology +2

About Osivax

Osivax is a clinical-stage biopharmaceutical company founded in 2017, with its headquarters in France. The company is pioneering a new class of universal vaccines utilizing the oligoDOM® nanoparticle platform technology. Their flagship product, OVX836, a broad-spectrum "universal" influenza candidate, is currently in P...

Taxonomy

Immunology, Vaccine, Infectious Diseases, Pan-respiratory Virus, Cellular Immune Response, CD8 T-cell, Immuno-oncology, Nanoparticle Platform Technology, Clinical-stage Biopharmaceutical Company, Universal Vaccines, Ovx836, OligODOM, Sarbocovirus, Clinical Trials

Frequently Asked Questions

Companies similar to Osivax include Mucosis, Novavax, VBI Vaccines Inc., Providence Therapeutics, iTeos Therapeutics. They work in Biotechnology and Health Care and share Osivax's focus on infectious diseases, clinical trials and immuno-oncology.

Bounce Watch lists 12 companies that share Osivax's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Osivax and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Osivax Profile Novavax Alternatives VBI Vaccines Inc. Alternatives Providence Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Osivax on 11 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.